These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 7537755)

  • 41. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.
    Falcioni R; Cimino L; Gentileschi MP; D'Agnano I; Zupi G; Kennel SJ; Sacchi A
    Exp Cell Res; 1994 Jan; 210(1):113-22. PubMed ID: 7505746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro properties of human melanoma cells metastatic in nude mice.
    Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.
    Albelda SM; Mette SA; Elder DE; Stewart R; Damjanovich L; Herlyn M; Buck CA
    Cancer Res; 1990 Oct; 50(20):6757-64. PubMed ID: 2208139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.
    Sato S; Kopitz C; Grismayer B; Beaufort N; Reuning U; Schmitt M; Luther T; Kotzsch M; Krüger A; Magdolen V
    Breast Cancer Res Treat; 2011 Jun; 127(3):649-57. PubMed ID: 20635136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis.
    Trikha M; De Clerck YA; Markland FS
    Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal and spatial regulation of integrin vitronectin receptor mRNAs in the embryonic chick retina.
    Gervin DB; Cann GM; Clegg DO
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1084-96. PubMed ID: 8631624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
    van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
    Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M; Parry GC; Strömblad S; Mackman N; Rosenberg S; Mueller BM; Cheresh DA
    J Biol Chem; 1996 Nov; 271(46):29393-9. PubMed ID: 8910604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of vitronectin receptor expression by retinoic acid on human melanoma cells.
    Santos CL; Giorgi RR; Frochtengarten F; Elias MC; Chammas R; Brentani RR
    Int J Clin Lab Res; 1994; 24(3):148-53. PubMed ID: 7529599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of integrin function by the urokinase receptor.
    Wei Y; Lukashev M; Simon DI; Bodary SC; Rosenberg S; Doyle MV; Chapman HA
    Science; 1996 Sep; 273(5281):1551-5. PubMed ID: 8703217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrin expression in uveal melanoma differs from cutaneous melanoma.
    ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.
    Hendrix MJ; Wood WR; Seftor EA; Lotan D; Nakajima M; Misiorowski RL; Seftor RE; Stetler-Stevenson WG; Bevacqua SJ; Liotta LA
    Cancer Res; 1990 Jul; 50(13):4121-30. PubMed ID: 2162253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.
    Boyd D; Florent G; Kim P; Brattain M
    Cancer Res; 1988 Jun; 48(11):3112-6. PubMed ID: 2835152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell surface proteolysis by serine proteinases enhances RGD-sensitive melanoma cell adhesion on fibrinogen and vitronectin.
    Fujii K; Imamura S
    Exp Cell Res; 1995 Sep; 220(1):201-11. PubMed ID: 7545129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RhoB regulates uPAR signalling.
    Alfano D; Ragno P; Stoppelli MP; Ridley AJ
    J Cell Sci; 2012 May; 125(Pt 10):2369-80. PubMed ID: 22366462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin.
    Reinartz J; Schäfer B; Batrla R; Klein CE; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):274-82. PubMed ID: 7556434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis.
    Leduc D; Beaufort N; de Bentzmann S; Rousselle JC; Namane A; Chignard M; Pidard D
    Infect Immun; 2007 Aug; 75(8):3848-58. PubMed ID: 17517866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.
    Stahl A; Mueller BM
    Int J Cancer; 1997 Mar; 71(1):116-22. PubMed ID: 9096674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection.
    Speth C; Pichler I; Stöckl G; Mair M; Dierich MP
    Immunobiology; 1998 Jul; 199(1):152-62. PubMed ID: 9717675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.